Loading...
Loading...
In a report published Thursday, Morgan Stanley analyst Andrew Schenker initiated coverage on
WellCare Health PlansWCG with an Underweight rating and $73.00 price target.
In the report, Morgan Stanley noted, “WCG will benefit long-term from Medicaid growth including expansion lives, duals, and new RFPs as well as Medicare Advantage growth. However, (1) reform implementation, (2) heightened industry competition, and (3) integration of recent acquisitions increase operational risk. Relatively high exposure to MA funding gap, particularly among pure-play Medicaid MCOs. Less favorable risk-reward.”
WellCare Health Plans closed on Wednesday at $70.76.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in